透析導管市場機會、成長要素、產業趨勢分析及2026-2035年預測。

預計到 2025 年，全球透析導管市場價值將達到 11.7 億美元，年複合成長率為 6.4%，到 2035 年將達到 22 億美元。

由於慢性腎臟病和末期腎功能衰竭的發生率不斷上升，以及對腎臟替代療法的依賴性日益增強，透析市場正在不斷擴張。糖尿病和高血壓病例的增加進一步推動了對有效透析解決方案的需求。透析導管是重要的醫療設備，當腎功能下降時，它能夠清除血液中的代謝廢物和多餘液體。這些器械大致可分為血液透析導管和腹膜透析導管，兩者在治療過程中都扮演著不可或缺的角色。隨著患者對更便利、更容易取得的治療方法的需求不斷成長，居家醫療的轉變正在顯著影響市場動態。導管設計的不斷進步，例如提高耐用性和降低感染風險，正在增強其長期可用性。此外，醫療保健支援計劃和協作系統的加強正在改善基礎設施和提高醫療服務的可近性，從而進一步促進市場成長。

到2025年，血液透析導管市場佔有率將達到90.9%，並隨著需要血液透析的患者人數不斷增加，持續推動市場成長。對可靠的血管通路解決方案的需求仍然至關重要，以確保治療效率和患者安全。這些導管旨在提供穩定的性能，同時最大限度地減少併發症，並正被越來越多的醫療機構採用。血液透析的規律性治療是持續需求的主要驅動力，因為患者需要可靠、可重複使用且能維持治療連續性的通路裝置。

預計到2025年，聚氨酯導管市場規模將達到10億美元，主要得益於其優異的材料性能，從而提升了臨床應用效果。聚氨酯導管因其柔軟性和結構強度而廣受歡迎，可有效防止使用過程中出現彎曲和堵塞等問題。其光滑的表面增強了整體功能性，並可能降低併發症的發生機率，使其更適合長期使用。持續的材料創新旨在提高患者舒適度和設備在長期治療環境中的可靠性，並不斷推動該領域的發展。

美國透析導管市場預計到2025年將達到4.25億美元，凸顯該地區的穩定成長。有利的醫保報銷政策和透析中心數量的增加，提高了患者獲得治療的機會，是推動市場擴張的主要因素。該地區對醫療技術的大力投資，正推動導管設計和性能的創新。材料、塗層和結構設計的持續改進，有助於改善患者治療效果，並促進產品更廣泛地應用。此外，完善的保險覆蓋範圍在確保透析相關產品價格合理、促進醫療機構更廣泛地使用方面發揮著至關重要的作用。

目錄

第1章：調查方法

• 研究途徑
• 品質改進計劃
  • GMI人工智慧政策及對資料完整性的承諾
    • 資訊來源一致性協議
• 調查過程和可靠性評分
  • 研究路徑的組成部分
  • 評分組成部分
• 數據收集
  • 主要來源部分列表
• 資料探勘資訊來源
  • 付費資訊來源
    • 區域資訊來源
• 基本估算和計算方法
  • 基準年的計算
• 預測模型
  • 量化市場影響分析
    • 生長參數對預測的數學影響
• 關於調查透明度的補充信息
  • 資訊來源歸屬框架
  • 品質保證指標
  • 對信任的承諾

第2章執行摘要

第3章業界考察

• 生態系分析
• 影響產業的因素
  • 促進因素
    • 慢性腎臟病和末期腎功能衰竭的盛行率增加
    • 腎臟替代療法增加
    • 居家醫療機構的治療趨勢
    • 全球腎臟捐贈者短缺
  • 產業潛在風險與挑戰
    • 人們越來越傾向於選擇動靜脈瘻管和植皮而不是導管。
    • 透析導管相關併發症
  • 機會
    • 抗菌和感染控制導管的研發
    • 居家血液透析的廣泛應用
• 成長潛力分析
• 監理情勢（基於初步調查）
  • 北美洲
  • 歐洲
  • 亞太地區
• 科技與創新趨勢
  • 當前技術趨勢
  • 新興技術（基於初步調查）
• 未來市場趨勢（基於初步研究）
• 救贖方案
• 人工智慧和生成式人工智慧對市場的影響（基於初步研究）
  • 利用人工智慧改造現有經營模式
  • 按細分市場分類的生成式人工智慧用例和部署藍圖
• 2025年各類產品的價格趨勢（基於初步調查）
• 差距分析
• 波特五力分析
• PESTEL 分析

第4章 競爭情勢

• 介紹
• 企業矩陣分析
• 企業市佔率分析
  • 世界
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲（MEA）
• 主要市場公司的競爭分析
• 競爭定位矩陣
• 主要進展
  • 併購
  • 夥伴關係與合作
  • 新產品發布
  • 業務拓展計劃

第5章 市場估計與預測：依類型分類，2022-2035年

• 血液透析導管
  • 短期血液透析導管
  • 長期血液透析導管
• 腹膜透析導管

第6章 市場估計與預測：依材料分類，2022-2035年

• 矽酮
• 聚氨酯

第7章 市場估計與預測：依最終用途分類，2022-2035年

• 醫院
• 門診手術中心
• 居家醫療設施
• 其他最終用戶

第8章 市場估計與預測：依地區分類，2022-2035年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• Amecath Medical Technologies
• Angiplast
• B Braun
• Baxter International
• Becton, Dickinson and Company
• Cook Medical
• Medtronic
• Merit Medical Systems
• PFM Medical, Inc.
• Poly Medicure
• Teleflex
• Vygon

The Global Dialysis Catheters Market was valued at USD 1.17 billion in 2025 and is estimated to grow at a CAGR of 6.4% to reach USD 2.2 billion by 2035.

The market is expanding due to the rising incidence of chronic kidney conditions and end-stage renal disease, along with a growing reliance on renal replacement therapies. Increasing cases of diabetes and hypertension are further contributing to the demand for effective dialysis solutions. Dialysis catheters serve as critical medical devices that enable the removal of waste and excess fluids from the bloodstream when kidney function is impaired. These devices are broadly categorized into hemodialysis and peritoneal dialysis catheters, both of which play essential roles in treatment delivery. The shift toward home-based healthcare is significantly influencing market dynamics, as patients increasingly seek convenient and accessible treatment options. Continuous advancements in catheter design, including enhanced durability and reduced risk of infection, are improving long-term usability. Additionally, supportive healthcare initiatives and collaborative efforts are strengthening infrastructure and accessibility, further driving market growth.

The hemodialysis catheters segment held a 90.9% share in 2025 and continues to lead the market due to the growing patient population requiring hemodialysis procedures. The need for dependable vascular access solutions remains critical to ensure treatment efficiency and patient safety. These catheters are designed to provide consistent performance while minimizing complications, which increases their adoption across healthcare facilities. Regular treatment schedules associated with hemodialysis contribute to sustained demand, as patients require reliable access devices that support repeated use and maintain treatment continuity.

The polyurethane segment generated USD 1 billion in 2025, driven by its favorable material characteristics that support clinical performance. Polyurethane-based catheters are widely preferred due to their flexibility and structural strength, which help prevent issues such as bending or blockage during use. Their smooth surface enhances overall functionality and may reduce the likelihood of complications, supporting their suitability for extended use. The segment continues to benefit from ongoing material innovations aimed at improving patient comfort and device reliability in long-term treatment settings.

U.S. Dialysis Catheters Market was valued at USD 425 million in 2025, highlighting consistent growth within the region. Market expansion is supported by favorable reimbursement structures and the increasing number of dialysis centers, which enhance treatment accessibility. The region demonstrates strong investment in healthcare technologies, driving innovation in catheter design and performance. Continuous improvements in materials, coatings, and structural design are contributing to better patient outcomes and increased product adoption. In addition, supportive insurance coverage plays a key role in ensuring affordability and encouraging wider use of dialysis-related products across healthcare facilities.

Key players operating in the Global Dialysis Catheters Market include Amecath Medical Technologies, Angiplast, B Braun, Baxter International, Becton, Dickinson and Company, Cook Medical, Medtronic, Merit Medical Systems, PFM Medical, Inc., Poly Medicure, Teleflex, and Vygon. Companies in the dialysis catheters market are strengthening their competitive position through continuous innovation, strategic partnerships, and expansion of production capabilities. Manufacturers are investing in advanced materials and improved catheter designs to enhance safety, durability, and patient comfort. Collaborations with healthcare providers and research institutions are enabling the development of more efficient and clinically effective solutions. Firms are also focusing on expanding their geographic footprint to tap into emerging markets with growing healthcare infrastructure. In addition, companies are optimizing supply chains and investing in quality assurance processes to ensure consistent product performance. Emphasis on regulatory compliance and product differentiation is further helping organizations maintain a strong presence in a competitive landscape.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Type trends
  • 2.2.3 Material trends
  • 2.2.4 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of chronic kidney disorders & end-stage renal disease
    • 3.2.1.2 Rising number of renal replacement therapy
    • 3.2.1.3 Growing trend of treatments in homecare settings
    • 3.2.1.4 Shortage of kidney donors globally
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Growing preference for fistulas and grafts over catheters
    • 3.2.2.2 Complications associated with dialysis catheters
  • 3.2.3 Opportunities
    • 3.2.3.1 Development of antimicrobial and infection-resistant catheters
    • 3.2.3.2 Growth of home hemodialysis adoption
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape (Driven by Primary Research)
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies (Driven by Primary Research)
• 3.6 Future market trends (Driven by Primary Research)
• 3.7 Reimbursement scenario
• 3.8 Impact of AI & generative AI on the market (Driven by Primary Research)
  • 3.8.1 AI-Driven disruption of existing business models
  • 3.8.2 GenAI use cases & adoption roadmap by segment
• 3.9 Price trends, by type, 2025 (Driven by Primary Research)
• 3.10 Gap analysis
• 3.11 Porter's analysis
• 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
  • 4.3.5 Latin America
  • 4.3.6 MEA
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn & Units)

• 5.1 Key trends
• 5.2 Hemodialysis catheters
  • 5.2.1 Short-term hemodialysis catheters
  • 5.2.2 Long-term hemodialysis catheters
• 5.3 Peritoneal catheters

Chapter 6 Market Estimates and Forecast, By Material, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Silicone
• 6.3 Polyurethane

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Homecare settings
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn & Units)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Amecath Medical Technologies
• 9.2 Angiplast
• 9.3 B Braun
• 9.4 Baxter International
• 9.5 Becton, Dickinson and Company
• 9.6 Cook Medical
• 9.7 Medtronic
• 9.8 Merit Medical Systems
• 9.9 PFM Medical, Inc.
• 9.10 Poly Medicure
• 9.11 Teleflex
• 9.12 Vygon